DiaMedica Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Note 13 - Related Party Transaction (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Vice President [Member] \| Consulting Services [Member] \| Research and Development Expense [Member]
Related Party Transaction, Amounts of Transaction	$ 149,000	$ 235,000